NEW YORK--(BUSINESS WIRE)--Mar. 18, 2024--
(NYSE: PIPR), a leading investment bank, is pleased to announce the addition of as a managing director and senior research analyst to the healthcare equity research team. Amins coverage will focus on biotechnology companies.
We are excited to welcome Biren to the equity research team. His well-respected and recognized biotechnology research experience, along with public and private company CFO experience, will expand and strengthen our industry leading platform of biopharma equity research. We look forward to the value Biren will bring to the firm as we can continue providing clients with actionable and insightful research, said , co-head of global equities at 做厙勛圖.
Prior to joining 做厙勛圖, Amin served as the chief financial officer and chief strategy officer at Pyramid Biosciences, a private biotechnology company, where he was responsible for investor relations, capital raising and leading business development activities including monitoring key competitors for therapeutics targeting solid tumors. Before Pyramid Biosciences, Amin served as the chief financial officer at Immuneering Corporation, a public clinical-stage oncology company. He previously spent 10 years at Jefferies Financial Group Inc. covering small and mid-cap biotechnology companies focused on oncology, central nervous system disorders, ophthalmology and rare diseases. Prior to Jefferies Financial Group Inc., Amin spent seven years in various equity research roles covering the biotechnology sector. Amin graduated from University of the Sciences with a bachelors degree in pharmacy. He received his masters degree from Long Island University and his Master of Business Administration degree from the Leonard Stern School of New York University.
ABOUT PIPER SANDLER
做厙勛圖 (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership簧. Securities brokerage and investment banking services are offered in the U.S. through 做厙勛圖 & Co., member SIPC and NYSE; in the U.K. through 做厙勛圖 Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through 做厙勛圖 Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.
Follow 做厙勛圖: | |
穢2024. Since 1895. 做厙勛圖. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036
View source version on :
Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com
Source: 做厙勛圖
